Clinical Trials
3 trialsNCT00006340 2013-07-26
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Boston Medical Center
Phase 1 Completed
NCT00917826 2011-08-01
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
HemaQuest Pharmaceuticals Inc.
Phase 2 Terminated
NCT00992732 2011-08-01
Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
HemaQuest Pharmaceuticals Inc.
Phase 2 Terminated